Contribute Try STAT+ Today

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is rather modest. We plan to promenade with the official mascot and survey an institution of higher learning or two with our short person. And what about you? Spring is about to spring, so this may be a good time to enjoy the great outdoors. You could make plans to get vaccinated or file your taxes — the treasury could use the money. Well, whatever you do, have a grand time. But be safe, wear a mask. Enjoy, and see you soon. …

Tony Fauci, the top U.S. infectious disease doctor, says the U.S. may not need the AstraZeneca (AZN) Covid-19 vaccine, even if it wins regulatory approval, Reuters tells us. The vaccine, once hailed as another milestone in the fight against the pandemic, has been dogged by questions since late last year, even as it has been authorized for use by dozens of countries, although not the U.S. Fauci says the U.S. has enough contracts with other vaccine makers to vaccinate its entire population, and possibly enough for booster shots in the fall.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Comments are closed.